Fraunhofer Institute for Toxicology and Experimental Medicine
Miniature Hearts: Cardiac Organoids With an Immune System
Multicellular human cardiac organoids for drug research.
more info© Fraunhofer ITEM
"Models of Lung Disease"
June 19-20, 2025 | Fraunhofer ITEM, Hannover (DE)
more info© LuckyStep / AntonKhrupinArt, stock.adobe.com
Phage therapy: hope in the fight against antibiotic-resistant germs
Scientists at Fraunhofer ITEM are taking up the challenge of bringing phage therapies safely and efficiently into clinical application.
more info© Jonas Ratermann
Toxicological assessment of e-liquids
Project EVape helps improve consumer safety in the e-cigarette segment.
© Fraunhofer ITEM, Ralf Mohr
"RNA-Based Therapeutics"
September 10-11, 2025 | Symposium at Fraunhofer ITEM, Hannover (DE)
more info© nobeastsofierce, stock.adobe.com
About Fraunhofer ITEM
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 76 institutes and research institutions of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on lung research, our R&D portfolio includes three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.
With a staff of around 450 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.